Samuel Paullin

Cooley advised Jump Crypto as a sponsor in connection with $1.65 billion in cash and stablecoin commitments for a private investment in public equity (PIPE) offering by Forward Industries, a global design company serving top-tier medical and technology companies, to initiate a Solana-focused digital asset treasury strategy, aligning Forward Industries with the fast-growing Solana ecosystem.

Cooley advised Ambiq Micro, a technology leader in ultra-low-power semiconductor solutions for edge artificial intelligence, on its $96 million initial public offering (IPO).

Cooley advised Tempus AI (Nasdaq: TEM), a technology company advancing precision medicine and patient care through artificial intelligence, on its offering of $650 million aggregate principal amount of 0.75% convertible senior notes due 2030 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Cooley advised Milestone Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, on its refreshment of its board of directors and cooperation agreement with Alta Fundamental Advisers.

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.